US Stock MarketDetailed Quotes

OLMA Olema Pharmaceuticals

Watchlist
  • 10.040
  • +0.320+3.29%
Trading Nov 27 09:45 ET
575.27MMarket Cap-4403P/E (TTM)

Olema Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-18.78%-27.02M
-24.59%-27.56M
-15.23%-23.5M
-2.03%-83.73M
6.27%-18.48M
-26.41%-22.74M
16.41%-22.12M
-13.90%-20.39M
-61.90%-82.07M
-5.96%-19.71M
Net income from continuing operations
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
Operating gains losses
----
----
----
--111K
--0
--103K
----
----
----
----
Depreciation and amortization
5.56%95K
-5.05%94K
-12.00%88K
5.60%377K
-9.28%88K
-1.10%90K
16.47%99K
19.05%100K
119.02%357K
32.88%97K
Other non cash items
-10.00%288K
121.09%2.64M
-281.37%-2.07M
-922.37%-4.23M
-1,027.98%-5.2M
-2.14%320K
267.69%1.2M
-267.80%-542K
-58.01%514K
---461K
Change In working capital
177.11%3.53M
80.31%-1.09M
22.58%4.54M
-119.49%-589K
230.71%5.8M
-2,135.11%-4.58M
-526.99%-5.52M
1,576.89%3.71M
6.78%3.02M
159.59%1.76M
-Change in prepaid assets
-23.33%-148K
104.82%30K
53.91%1.59M
135.43%694K
119.85%401K
16.08%-120K
-2,043.75%-622K
501.74%1.04M
-4,797.50%-1.96M
-58.81%-2.02M
-Change in payables and accrued expense
-386.77%-1.67M
-449.79%-3.3M
1,514.98%4.96M
562.11%2.32M
36.39%491K
649.06%582K
737.84%944K
25.31%307K
151.39%351K
330.77%360K
-Change in other current assets
96.79%-167K
-711.28%-1.08M
---1.34M
-377.92%-5.32M
--4K
-808.22%-5.2M
55.96%-133K
--0
-3,613.33%-1.11M
--0
-Change in other current liabilities
3,481.17%5.52M
157.16%3.26M
-128.08%-664K
-70.11%1.72M
43.72%4.91M
-85.28%154K
-433.72%-5.71M
652.57%2.37M
60.31%5.74M
329.66%3.42M
Cash from discontinued investing activities
Operating cash flow
-18.78%-27.02M
-24.59%-27.56M
-15.23%-23.5M
-2.03%-83.73M
6.27%-18.48M
-26.41%-22.74M
16.41%-22.12M
-13.90%-20.39M
-61.90%-82.07M
-5.96%-19.71M
Investing cash flow
Cash flow from continuing investing activities
280.53%45.92M
-134.56%-4.88M
-153.88%-20.14M
-105.30%-4.85M
-289.24%-30.92M
-226.15%-25.44M
-52.02%14.11M
46.23%37.39M
133.21%91.48M
172.27%16.34M
Net PPE purchase and sale
--0
---6K
---153K
103.86%14K
--0
110.07%14K
--0
--0
76.95%-363K
75.25%-173K
Net investment purchase and sale
280.43%45.92M
-134.52%-4.87M
-153.47%-19.99M
-105.30%-4.87M
-287.26%-30.92M
-225.35%-25.45M
-52.05%14.11M
46.06%37.39M
133.54%91.84M
146.44%16.51M
Cash from discontinued investing activities
Investing cash flow
280.53%45.92M
-134.56%-4.88M
-153.88%-20.14M
-105.30%-4.85M
-289.24%-30.92M
-226.15%-25.44M
-52.02%14.11M
46.23%37.39M
133.21%91.48M
172.27%16.34M
Financing cash flow
Cash flow from continuing financing activities
-99.93%92K
663.83%15.61M
3,909.55%8.82M
27,928.36%133.42M
91.58%523K
123,134.91%130.63M
3,092.19%2.04M
566.67%220K
-65.78%476K
-66.63%273K
Net common stock issuance
--0
--14.89M
--7.9M
--129.74M
---24K
--129.76M
--0
--0
--0
--0
Proceeds from stock option exercised by employees
-89.41%92K
-64.81%719K
318.18%920K
672.90%3.68M
100.37%547K
719.81%869K
3,092.19%2.04M
566.67%220K
-65.78%476K
-66.63%273K
Cash from discontinued financing activities
Financing cash flow
-99.93%92K
663.83%15.61M
3,909.55%8.82M
27,928.36%133.42M
91.58%523K
123,134.91%130.63M
3,092.19%2.04M
566.67%220K
-65.78%476K
-66.63%273K
Net cash flow
Beginning cash position
-51.68%16.89M
-17.59%33.72M
189.17%68.54M
71.60%23.7M
338.02%117.41M
42.53%34.96M
90.24%40.92M
71.60%23.7M
-95.92%13.81M
4.72%26.8M
Current changes in cash
-76.96%19M
-182.35%-16.83M
-302.25%-34.82M
353.36%44.84M
-1,475.37%-48.87M
3,519.36%82.45M
-297.55%-5.96M
123.67%17.22M
103.05%9.89M
73.68%-3.1M
End cash Position
-69.43%35.89M
-51.68%16.89M
-17.59%33.72M
189.17%68.54M
189.17%68.54M
338.02%117.41M
42.53%34.96M
90.24%40.92M
71.60%23.7M
71.60%23.7M
Free cash flow
-18.78%-27.02M
-24.62%-27.56M
-15.98%-23.65M
-1.58%-83.73M
7.08%-18.48M
-25.44%-22.74M
16.48%-22.12M
-13.71%-20.39M
-57.71%-82.43M
-3.02%-19.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -18.78%-27.02M-24.59%-27.56M-15.23%-23.5M-2.03%-83.73M6.27%-18.48M-26.41%-22.74M16.41%-22.12M-13.90%-20.39M-61.90%-82.07M-5.96%-19.71M
Net income from continuing operations -60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M
Operating gains losses --------------111K--0--103K----------------
Depreciation and amortization 5.56%95K-5.05%94K-12.00%88K5.60%377K-9.28%88K-1.10%90K16.47%99K19.05%100K119.02%357K32.88%97K
Other non cash items -10.00%288K121.09%2.64M-281.37%-2.07M-922.37%-4.23M-1,027.98%-5.2M-2.14%320K267.69%1.2M-267.80%-542K-58.01%514K---461K
Change In working capital 177.11%3.53M80.31%-1.09M22.58%4.54M-119.49%-589K230.71%5.8M-2,135.11%-4.58M-526.99%-5.52M1,576.89%3.71M6.78%3.02M159.59%1.76M
-Change in prepaid assets -23.33%-148K104.82%30K53.91%1.59M135.43%694K119.85%401K16.08%-120K-2,043.75%-622K501.74%1.04M-4,797.50%-1.96M-58.81%-2.02M
-Change in payables and accrued expense -386.77%-1.67M-449.79%-3.3M1,514.98%4.96M562.11%2.32M36.39%491K649.06%582K737.84%944K25.31%307K151.39%351K330.77%360K
-Change in other current assets 96.79%-167K-711.28%-1.08M---1.34M-377.92%-5.32M--4K-808.22%-5.2M55.96%-133K--0-3,613.33%-1.11M--0
-Change in other current liabilities 3,481.17%5.52M157.16%3.26M-128.08%-664K-70.11%1.72M43.72%4.91M-85.28%154K-433.72%-5.71M652.57%2.37M60.31%5.74M329.66%3.42M
Cash from discontinued investing activities
Operating cash flow -18.78%-27.02M-24.59%-27.56M-15.23%-23.5M-2.03%-83.73M6.27%-18.48M-26.41%-22.74M16.41%-22.12M-13.90%-20.39M-61.90%-82.07M-5.96%-19.71M
Investing cash flow
Cash flow from continuing investing activities 280.53%45.92M-134.56%-4.88M-153.88%-20.14M-105.30%-4.85M-289.24%-30.92M-226.15%-25.44M-52.02%14.11M46.23%37.39M133.21%91.48M172.27%16.34M
Net PPE purchase and sale --0---6K---153K103.86%14K--0110.07%14K--0--076.95%-363K75.25%-173K
Net investment purchase and sale 280.43%45.92M-134.52%-4.87M-153.47%-19.99M-105.30%-4.87M-287.26%-30.92M-225.35%-25.45M-52.05%14.11M46.06%37.39M133.54%91.84M146.44%16.51M
Cash from discontinued investing activities
Investing cash flow 280.53%45.92M-134.56%-4.88M-153.88%-20.14M-105.30%-4.85M-289.24%-30.92M-226.15%-25.44M-52.02%14.11M46.23%37.39M133.21%91.48M172.27%16.34M
Financing cash flow
Cash flow from continuing financing activities -99.93%92K663.83%15.61M3,909.55%8.82M27,928.36%133.42M91.58%523K123,134.91%130.63M3,092.19%2.04M566.67%220K-65.78%476K-66.63%273K
Net common stock issuance --0--14.89M--7.9M--129.74M---24K--129.76M--0--0--0--0
Proceeds from stock option exercised by employees -89.41%92K-64.81%719K318.18%920K672.90%3.68M100.37%547K719.81%869K3,092.19%2.04M566.67%220K-65.78%476K-66.63%273K
Cash from discontinued financing activities
Financing cash flow -99.93%92K663.83%15.61M3,909.55%8.82M27,928.36%133.42M91.58%523K123,134.91%130.63M3,092.19%2.04M566.67%220K-65.78%476K-66.63%273K
Net cash flow
Beginning cash position -51.68%16.89M-17.59%33.72M189.17%68.54M71.60%23.7M338.02%117.41M42.53%34.96M90.24%40.92M71.60%23.7M-95.92%13.81M4.72%26.8M
Current changes in cash -76.96%19M-182.35%-16.83M-302.25%-34.82M353.36%44.84M-1,475.37%-48.87M3,519.36%82.45M-297.55%-5.96M123.67%17.22M103.05%9.89M73.68%-3.1M
End cash Position -69.43%35.89M-51.68%16.89M-17.59%33.72M189.17%68.54M189.17%68.54M338.02%117.41M42.53%34.96M90.24%40.92M71.60%23.7M71.60%23.7M
Free cash flow -18.78%-27.02M-24.62%-27.56M-15.98%-23.65M-1.58%-83.73M7.08%-18.48M-25.44%-22.74M16.48%-22.12M-13.71%-20.39M-57.71%-82.43M-3.02%-19.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data